Specialty Sales Representative

Arrowhead Pharmaceuticals

This is a unique opportunity to play a meaningful role in the launch and growth of our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3), developed for patients with rare and high-need cardiovascular conditions such as Familial Chylomicronemia Syndrome (FCS) and Severe Hypertri

Last checked on June 28, 2026. We may earn a commission when you click through.

Advertisement
This listing may have expired or is no longer available. Information shown may be outdated.

Specialty Sales Representative

Arrowhead Pharmaceuticals

Updated 1 month ago
Apply now

You'll be redirected to talent.com

Brooklyn

You might also like

Related Articles